Can a clot-busting enzyme ease long COVID and chronic fatigue?
NCT ID NCT06511050
First seen Mar 23, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This early-stage study tests lumbrokinase, an enzyme that breaks down blood clots, in 120 adults with Long COVID, post-treatment Lyme disease syndrome, or ME/CFS. Participants rate their overall health before and after treatment to see if the enzyme improves quality of life. The goal is to find out if this approach is worth studying further for these hard-to-treat conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.